| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 64049-91-8 | Benzenemethanaminium,N,N-dimethyl-N-[4-methyl-3-[[(methylamino)carbonyl]oxy]phenyl]-, chloride (1:1); Benzenemethanaminium,N,N-dimethyl-N-[4-methyl-3-[[(methylamino)carbonyl]oxy]phenyl]-, chloride (9CI) |  | C18H23N2O2.Cl | 詳情 | 供應商 | |
| 6267-67-0 | Ethanone,1-[4-(dimethylamino)phenyl]-2-[(2-hydroxyethyl)amino]-2-phenyl-, hydrochloride(9CI); NSC34587 |  | C18H23ClN2O2 | 詳情 | 供應商 | |
| 620-99-5 | Ethanimidamide,N,N'-bis(4-ethoxyphenyl)-, hydrochloride (1:1); Acetamidine,N,N'-bis(p-ethoxyphenyl)-, hydrochloride (7CI); Acetamidine, N,N'-bis(p-ethoxyphenyl)-,monohydrochloride (8CI); Ethanimidamide, N,N'-bis(4-ethoxyphenyl)-,monohydrochloride (9CI); Holocaine hydrochloride; Phenacaine hydrochloride |  | C18H23ClN2O2 | 詳情 | 供應商 | |
| 139193-91-2 | Isoxazole,3-methyl-5-[2-[2-[2-(1-pyrrolidinyl)ethoxy]phenyl]ethenyl]-, monohydrochloride,(E)- (9CI); 3-methyl-5-[(E)-2-[2-(2-pyrrolidin-1-ylethoxy)phenyl]ethenyl]oxazole h ydrochloride |  | C18H23ClN2O2 | 詳情 | 供應商 | |
| 139193-89-8 | Morpholine,4-[2-[2-[2-(3-methyl-5-isoxazolyl)ethenyl]phenoxy]ethyl]-, monohydrochloride,(E)- (9CI); 4-[2-[2-[(E)-2-(3-methyloxazol-5-yl)ethenyl]phenoxy]ethyl]morpholine h ydrochloride |  | C18H23ClN2O3 | 詳情 | 供應商 | |
| 303-25-3 | 鹽酸苯甲嗪; 鹽酸苯甲嗪 | Piperazine,1-(diphenylmethyl)-4-methyl-, hydrochloride (1:1); Piperazine,1-(diphenylmethyl)-4-methyl-, monohydrochloride (8CI,9CI); CyClizinehydrochloride; Marezine hydrochloride; Marzine; N-Benzhydryl-N'-methylpiperazine monohydrochloride |  | C18H23ClN2 | 詳情 | 供應商 |
| 24342-54-9 | Piperazine,1-[(2-methylphenyl)phenylmethyl]-, hydrochloride (1:?); Piperazine,1-(o-methyl-a-phenylbenzyl)-,hydrochloride (6CI,8CI); Piperazine, 1-[(2-methylphenyl)phenylmethyl]-,hydrochloride (9CI); NormethylcyClizine hydrochloride |  | C18H23ClN2 | 詳情 | 供應商 | |
| 129-71-5 | Piperazine,1-[(4-chlorophenyl)phenylmethyl]-4-methyl-, hydrochloride (1:2); Piperazine,1-(p-chloro-a-phenylbenzyl)-4-methyl-,dihydrochloride (8CI); Piperazine, 1-[(4-chlorophenyl)phenylmethyl]-4-methyl-,dihydrochloride (9CI); 47-282; AH 289; ChlorcyClazine dihydrochloride; ChlorcyClizine dihydrochloride; Histantine dihydrochloride; N-Methyl-N'-(4-chlorobenzhydryl)piperazine dihydrochloride; Perazil dihydrochloride |  | C18H23Cl3N2 | 詳情 | 供應商 | |
| 6953-49-7 | Pyridinium,5-(aminocarbonyl)-2-methoxy-1-(2,3,5-tri-O-acetyl-b-D-ribofuranosyl)-, chloride (9CI); NSC71363 |  | C18H23N2O9.Cl | 詳情 | 供應商 | |
| 864759-66-0 | Piperazine,1-[(2-methoxyphenyl)sulfonyl]-4-(phenylmethyl)-, hydrochloride (1:1); Piperazine,1-[(2-methoxyphenyl)sulfonyl]-4-(phenylmethyl)-, monohydrochloride (9CI) |  | C18H23ClN2O3S | 詳情 | 供應商 | |
| 58-28-6 | 3-氟茴香硫醚; 鹽酸去甲丙咪嗪 | 10,11-Dihydro-5-(3-(methylamino)prop-yl)-5h-dibenz(b,f)azepine hydro-chloride; 5H-Dibenz[b,f]azepine,10,11-dihydro-5-[3-(methylamino)propyl]-, monohydrochloride (8CI); 5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N-methyl-, monohydrochloride(9CI); 10,11-Dihydro-5-[3-(methylamino)propyl]-5H-dibenz[b,f]azepinemonohydrochloride; 5-[3-(Methylamino)propyl]-5H-dibenz[b,f]azepinehydrochloride; DMI hydrochloride; Demethylimipramine hydrochloride; Desimipramine-hydrochloride; Desipramine hydrochloride; Desipraminemonohydrochloride; Desmethylimipramine chloride; Desmethylimipraminemonohydrochloride; Desmethylimipramine-hydrochloride; GMI; JB8181; N-(g-Methylaminopropyl)iminodibenzylhydrochloride; Norpramin; Nortrimil; Pertofran; Pertofrane; |  | C18H23ClN2 | 詳情 | 供應商 |
| 144576-50-1 | 1-Butanone,1-(3-phenyl-5-isoxazolyl)-2-(1-pyrrolidinylmethyl)-, hydrochloride (1:1), (2R)-; 1-Butanone,1-(3-phenyl-5-isoxazolyl)-2-(1-pyrrolidinylmethyl)-, monohydrochloride, (2R)-(9CI); 1-Butanone, 1-(3-phenyl-5-isoxazolyl)-2-(1-pyrrolidinylmethyl)-,monohydrochloride, (R)-; MS 322; MS 322 (musCle relaxant) |  | C18H23ClN2O2 | 詳情 | 供應商 | |
| 108260-30-6 | 1-Aziridineacetamide, a-[2-(4-chlorophenyl)-2-oxoethyl]-N-cyClohexyl- |  | C18H23ClN2O2 | 詳情 | 供應商 | |
| 100365-96-6 | 1-Propanone,1-(3,4-dihydrobenzofuro[3,2-c]pyridin-2(1H)-yl)-3-(1-pyrrolidinyl)-,hydrochloride (1:1); Benzofuro[3,2-c]pyridine,1,2,3,4-tetrahydro-2-[1-oxo-3-(1-pyrrolidinyl)propyl]-, monohydrochloride (9CI) |  | C18H23ClN2O2 | 詳情 | 供應商 | |
| 4784-40-1 | 10H-Phenothiazine-10-propanamine,N,N,b-trimethyl-, 5,5-dioxide,hydrochloride (1:1); 10H-Phenothiazine-10-propanamine,N,N,b-trimethyl-, 5,5-dioxide, monohydrochloride(9CI); Phenothiazine, 10-[3-(dimethylamino)-2-methylpropyl]-, 5,5-dioxide,monohydrochloride (8CI); Oxomemazine hydrochloride |  | C18H23ClN2O2S | 詳情 | 供應商 | |
| 76061-79-5 | 1H-Pyrazino[3,2,1-jk]carbazole,3-butyl-8-chloro-2,3,3a,4,5,6-hexahydro-, hydrochloride (1:1); 1H-Pyrazino[3,2,1-jk]carbazole,3-butyl-8-chloro-2,3,3a,4,5,6-hexahydro-, monohydrochloride (9CI) |  | C18H23ClN2.ClH | 詳情 | 供應商 | |
| 53387-49-8 | 2-Azocinamine,N-(2-furanylphenylmethyl)-3,4,5,6,7,8-hexahydro-, hydrochloride (1:1); 2-Azocinamine,N-(2-furanylphenylmethyl)-3,4,5,6,7,8-hexahydro-, monohydrochloride (9CI); NSC211499 |  | C18H23ClN2O | 詳情 | 供應商 | |
| 85187-27-5 | 2-Pyrrolidinecarboxamide,1-(4-chlorobenzoyl)-5-oxo-N,N-dipropyl-; 2-Pyrrolidinecarboxamide,1-(4-chlorobenzoyl)-5-oxo-N,N-dipropyl-, (?à)- |  | C18H23ClN2O3 | 詳情 | 供應商 | |
| 102043-61-8 | 4-Morpholineethanamine,N,N-diphenyl-, hydrochloride (1:1); 4-Morpholineethanamine,N,N-diphenyl-, monohydrochloride (9CI); Morpholine, 4-(2-diphenylaminoethyl)-,hydrochloride (6CI) |  | C18H23ClN2O | 詳情 | 供應商 | |
| 27432-01-5 | 5H-Dibenz[b,e]azepine-5-propanamine,6,11-dihydro-N-methyl-, hydrochloride (1:1); 5H-Dibenz[b,e]azepine-5-propanamine,6,11-dihydro-N-methyl-, monohydrochloride (9CI); Morphanthridine,5,6-dihydro-5-[3-(methylamino)propyl]-, monohydrochloride (8CI); Norpropazepinehydrochloride |  | C18H23ClN2 | 詳情 | 供應商 | |